Novo Nordisk brings Anthropic’s Claude into drug discovery as AI partnerships move deeper into pharmaceutical R&D
Novo Nordisk has expanded its artificial-intelligence strategy through a collaboration with Anthropic that will test Claude Science in pharmaceutical R&D, adding another AI partner as the drugmaker seeks faster research productivity amid intensifying competitive pressure.
